FY2025 · period end Jan '26 · from the 10-K filed Mar 3, 2026
Data as filed with the SEC, provided for information only — not investment advice.
| Metric | FY25Jan '26 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Jan '22 |
|---|---|---|---|---|---|
| Revenue | $1.05B | $1.05B | $0.96B | $0.90B | $0.79B |
| Gross Profit | $0.48B | $0.47B | $0.42B | $0.39B | $0.34B |
| Operating Income | $0.16B | $0.17B | $0.17B | $0.17B | $0.12B |
| Net Income | $0.10B | $0.11B | $0.12B | $0.12B | $0.08B |
| EPS (Diluted) | $8.65 | $9.48 | $9.90 | $10.35 | $7.21 |
| Metric | FY25Jan '26 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Jan '22 |
|---|---|---|---|---|---|
| Total Assets | $1.71B | $1.43B | $1.18B | $1.15B | $1.13B |
| Total Liabilities | — | — | — | — | — |
| Stockholders' Equity | $0.99B | $0.86B | $0.78B | $0.66B | $0.57B |
| Cash & Equivalents | $0.12B | $0.09B | $0.10B | $0.08B | $0.09B |
| Total Debt | $0.37B | $0.29B | $0.11B | $0.20B | $0.27B |
| Metric | FY25Jan '26 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Jan '22 |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.17B | $0.16B | $0.17B | $0.10B | $0.16B |
| Capital Expenditures | $0.02B | $0.02B | $0.03B | $0.03B | $0.01B |
| Free Cash Flow | $0.15B | $0.13B | $0.13B | $0.07B | $0.15B |
| Metric | FY25Jan '26 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Jan '22 |
|---|---|---|---|---|---|
| Gross Margin | 45.2% | 44.3% | 43.5% | 43.1% | 42.9% |
| Operating Margin | 0.1% | 0.2% | 0.2% | 0.2% | 14.8% |
| Net Margin | 0.1% | 0.1% | 0.1% | 0.1% | 10.7% |
| Return on Equity | 10.3% | 13.7% | 16.2% | 19.8% | 14.9% |
| Return on Assets | 6.0% | 8.6% | 10.0% | 10.6% | 7.4% |
| Debt / Equity | 0.38× | 0.34× | 0.14× | 0.31× | 0.48× |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or full history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0000886346-26-000055 | Sep 10, 2026 | Sep 10, 2026 | Sep 10, 2026 20:42 UTC | EDGAR |
| 10-Q | 0000886346-26-000052 | Jul 4, 2026 | Aug 12, 2026 | Aug 12, 2026 19:41 UTC | EDGAR |
| 8-K | 0000886346-26-000049 | Aug 4, 2026 | Aug 4, 2026 | Aug 4, 2026 20:47 UTC | EDGAR |
| 8-K | 0000886346-26-000043 | May 20, 2026 | May 26, 2026 | May 26, 2026 20:24 UTC | EDGAR |
| 10-Q | 0000886346-26-000040 | Apr 4, 2026 | May 13, 2026 | May 13, 2026 18:42 UTC | EDGAR |
| 8-K | 0000886346-26-000037 | May 5, 2026 | May 5, 2026 | May 5, 2026 20:51 UTC | EDGAR |
| 8-K | 0000886346-26-000034 | Apr 30, 2026 | Apr 30, 2026 | Apr 30, 2026 12:22 UTC | EDGAR |
| 10-K | 0000886346-26-000018 | Jan 3, 2026 | Mar 3, 2026 | Mar 3, 2026 21:47 UTC | EDGAR |
Direct links to SEC EDGAR. KAI has additional filings available on the SEC site.
6 numbers KADANT INC later changed — same XBRL tag, both filings linked.
Net Cash Provided by (Used in) Operating Activities·Q1 2015
Major restatementwas-$4.6M
Revised up in a 10-Q.
Net Cash Provided by (Used in) Operating Activities·Q2 2015
Major restatementwas$9.6M
Revised up in a 10-Q. Any P/OCF built on the original was 20.7% too high.
Net Cash Provided by (Used in) Operating Activities·Q3 2015
Notable restatementwas$25.5M
Revised up in a 10-Q. Any P/OCF built on the original was 8.9% too high.
Net Cash Provided by (Used in) Operating Activities·FY 2016
Notable restatementwas$37.9M
Revised up in a 10-K. Any P/OCF built on the original was 6.2% too high.
Net Cash Provided by (Used in) Operating Activities·FY 2015
Notable restatementwas$48.9M
Revised up in a 10-K. Any P/OCF built on the original was 4.4% too high.
Operating Income (Loss)·FY 2016
Notable restatementwas$45.6M
Revised up in a 10-K.
KAI is not the only one.
See every restatement we've found across the market — or get an alert the next time KAI revises a number.
Restatements are detected by comparing every vintage of a fact across all of KADANT INC's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows KAI's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling KADANT INC — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on KAI yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on KAI and publish the result to your public profile.
Ask about KADANT INC
Continue in Workspace — cited answers on KAI, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate, with delisted companies kept in.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs